Description
Track treatment progress, log symptoms, and receive reminders for medication and appointments. View study-specific updates and communicate with healthcare providers through secure messaging.
Phase 3 study of Early Breast Cancer with an increased risk of Recurrence. This app is specifically intended for site users in the J2J-MC-JZLH study only.